几种阿斯特拉加卢斯 (Fabaceae) 品种的化学成分和治疗作用
N K Klichkhanov1, M N Suleimanova2
1Dagestan State University, Makhachkala, Russia. klich-khan@mail.ru.
概括
这篇综述强调了34种阿斯特拉加勒斯种的化学组成和生物活动. 阿斯特拉加勒斯膜表现出显著的抗炎,免疫调节和抗氧化作用,但其他物种需要进一步研究.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 阿斯特拉加勒斯属 (Fabaceae) 富含生物活性化合物.
- 最近的研究 (5-7年) 专注于各种阿斯特拉加勒斯物种的化学成分和生物效应.
- 对研究较少的物种的全面了解仍然有限.
研究的目的:
- 审查和整合最近关于阿斯特拉加勒斯物种成分组成和生物活性的发现.
- 为了突出Astragalus membranaceus的记录良好的特性.
- 为了识别有关其他阿斯特拉加勒斯物种的知识差距.
主要方法:
- 关于过去5-7年发表的研究的文献综述.
- 报告的化学成分 (三烯素,黄类,多糖类等) 的分析. 从空中和地下部件.
- 实验检测到的生物活动 (体外和体内生物) 的汇编.
主要成果:
- 分析了34个阿斯特拉加卢斯物种,揭示了各种成分,包括三三酸盐酸,黄酸盐和多糖.
- 阿斯特拉加勒斯膜状 (鱼类) 是研究最广泛的物种.
- 在A. membranaceus和A. membranaceus var.中证实了显著的抗炎,免疫调节,抗氧化,抗癌,心脏保护和肝保护作用. 蒙古人. 蒙古人.
结论:
- 阿斯特拉加卢斯物种是生物活性化合物的宝贵来源,具有多种药理性质.
- 需要进一步的研究来阐明许多其他阿斯特拉加勒斯物种的组成和生物效应.
- 本综述总结了阿斯特拉加勒斯研究的近期进展,重点是A. membranaceus.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
267
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
267
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
243
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
243
01:28Structure-Activity Relationships and Drug Design
687
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
687
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
711
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
711